Van ECK Associates Corp Has $98.60 Million Holdings in CVS Health Corporation $CVS

Van ECK Associates Corp raised its stake in shares of CVS Health Corporation (NYSE:CVS) by 19.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,307,896 shares of the pharmacy operator’s stock after purchasing an additional 209,081 shares during the period. Van ECK Associates Corp owned 0.10% of CVS Health worth $98,602,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in CVS. Vanguard Group Inc. lifted its holdings in shares of CVS Health by 1.7% during the second quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock worth $8,305,132,000 after buying an additional 2,063,737 shares during the last quarter. Capital World Investors increased its position in CVS Health by 2.1% during the third quarter. Capital World Investors now owns 68,382,158 shares of the pharmacy operator’s stock worth $5,155,380,000 after acquiring an additional 1,419,575 shares during the period. State Street Corp grew its position in CVS Health by 1.4% in the 2nd quarter. State Street Corp now owns 58,788,585 shares of the pharmacy operator’s stock worth $4,055,237,000 after purchasing an additional 800,414 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of CVS Health by 2.4% during the 2nd quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock worth $1,966,083,000 after purchasing an additional 675,824 shares during the period. Finally, Capital International Investors lifted its stake in shares of CVS Health by 1.1% in the third quarter. Capital International Investors now owns 26,692,203 shares of the pharmacy operator’s stock valued at $2,012,347,000 after buying an additional 302,499 shares during the period. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

CVS stock opened at $76.15 on Wednesday. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. CVS Health Corporation has a twelve month low of $58.35 and a twelve month high of $85.15. The company has a market cap of $96.87 billion, a P/E ratio of 55.18, a price-to-earnings-growth ratio of 0.82 and a beta of 0.49. The business’s fifty day moving average is $78.39 and its 200-day moving average is $77.73.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same quarter last year, the business posted $1.19 EPS. The firm’s revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. CVS Health’s dividend payout ratio is currently 192.75%.

Analyst Ratings Changes

A number of analysts have commented on the company. Wells Fargo & Company reduced their price objective on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Truist Financial set a $100.00 target price on shares of CVS Health in a research report on Wednesday, December 10th. Piper Sandler restated an “overweight” rating and set a $101.00 price target (up from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Finally, UBS Group restated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Nineteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus target price of $94.91.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.